Axsome Therapeutics logo
Axsome Therapeutics AXSM
$ 89.64 0.0%

Quarterly report 2024-Q2
added 08-05-2024

report update icon

Axsome Therapeutics EV/EBITDA Ratio 2011-2024 | AXSM

Annual EV/EBITDA Ratio Axsome Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-8.03 -24.3 -41.9 -6.66 -1.47 -2.33 -6.58 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.47 -41.9 -13